Neuromag Institute
EXOMIND — BTL clinical device

Strengthen Your Mind

EXOMIND is a non-invasive, drug-free therapy using FDA-cleared ExoTMS™ technology to treat Major Depressive Disorder. Sessions are under 30 minutes. You walk in, you walk out, and you return to your day.

Book a consultationCall (813) 876-7246
A patient resting comfortably during an EXOMIND session — non-invasive, drug-free TMS therapy at Neuromag Institute, Tampa FL.
Why patients ask about EXOMIND

  • Comfortable

    Most patients describe it as a light tapping on the scalp.

  • Under 30 minutes

    Sessions fit before work, between meetings, on a lunch break.

  • Non-invasive · drug-free

    No anesthesia, no medication, no needles.

  • Walk in, walk out

    Zero recovery time. Return to driving and daily activities immediately.

The EXOMIND treatment device on its mobile stand, ready for a session.
The technology

ExoTMS™ — a modern evolution of TMS, used for depression since 2008.

ExoTMS™

EXOMIND uses patented ExoTMS™ technology to non-invasively stimulate the specific brain regions involved in emotional regulation, cognitive function, and self-control. By activating those neural pathways, it helps restore healthy brain activity and enhances neural connectivity.

Repetitive transcranial magnetic stimulation (rTMS) is a well-established class of treatment for Major Depressive Disorder. ExoTMS™ is BTL's next-generation implementation, engineered for patient comfort, operator-independent setup, and walk-in / walk-out workflow.

See it in motion

  • How EXOMIND works

    BTL's mechanism-of-action explainer — how ExoTMS™ pulses reach the brain regions involved in mood regulation.

The clinical picture

What the trials and the patients say.

  • 83%

    of patients with a depression diagnosis reported feeling less depressed three months after the last treatment.

  • 88%

    of all patients showed improved mental-wellbeing scores three months after treatment.

  • 0.2 / 10

    average pain rating during EXOMIND sessions (0 = no pain, 10 = worst possible).

  • 1,949

    patients across 37 randomized, sham-controlled trials of rTMS for depression underpinning the safety record.

Dees M., Halaas Y., McCoy J.D. — ExoTMS Technology: A Breakthrough in Transcranial Stimulation for Enhancing Mental Well-Being. Data on file with BTL Industries. Individual results vary.

What a session looks like

Designed to feel like a quiet appointment, not a procedure.

  1. 01

    Before

    Eat and drink normally. Take your usual medications unless your physician says otherwise. Skip alcohol and caffeine the day of your session. Wear loose, comfortable clothing. Remove any jewelry or metal near the head — the magnetic field interacts with metal.

  2. 02

    During

    You sit back. The applicator is positioned over the target brain region. You'll feel a light tapping or tingling on the scalp as the magnetic pulses fire. No anesthesia, no medication. The therapy should never be painful — if anything is uncomfortable, we adjust the settings on the spot.

  3. 03

    Sound

    EXOMIND emits a loud, rhythmic clicking sound during treatment.

  4. 04

    After

    No recovery time. You can drive, return to work, and resume your full day immediately. Your provider monitors progress between sessions and adjusts the protocol as needed.

Who EXOMIND is for

FDA-cleared scope and the safety lines we hold to.

A full patient consent form and informed-consent conversation with Dr. Libreros precedes any EXOMIND treatment. The list above is a summary of the BTL Sample Patient Consent Form — the complete document and a personal discussion are part of your evaluation visit. If you are in crisis or having thoughts of self-harm, call or text 988 (Suicide & Crisis Lifeline) or 911.

What patients say

From the BTL national patient program.

  • “

    I really felt it each treatment. I felt it getting better, and better, and my happiness, my joy, everything came back.

    Jennifer

    Phoenix, AZ

  • “

    It was easy — just felt like some tapping on my head. And that was really it. It wasn't uncomfortable in the slightest.

    Brianna

    Denver, CO

  • “

    I am just overall happier. That's what I noticed. I honestly do believe that EXOMIND has changed my life.

    Katherine

    Phoenix, AZ

Frequently asked

The questions patients ask most before booking.

Is EXOMIND right for me?

EXOMIND is FDA-cleared for adults with Major Depressive Disorder who have not had satisfactory improvement from antidepressant medication in the current episode. The clearest way to know is a consultation with Dr. Libreros — we review your history, current medications, contraindications, and goals before recommending anything.

Does it hurt?

Most patients describe the sensation as a light tapping or tingling on the scalp. The average pain rating across reported BTL data is 0.2 out of 10. If anything is uncomfortable during a session, settings are adjusted on the spot. Therapy should never be painful.

Will I be able to drive home? Will it disrupt my daily life?

Yes. EXOMIND is walk-in, walk-out — no anesthesia, no recovery time. You can drive, return to work, and resume your normal day immediately after a session.

How many sessions will I need?

Course length is individualized and determined by Dr. Libreros in consultation, based on your history and response. We discuss the expected course at your evaluation visit before you commit to a treatment plan.

Will my insurance cover it?

Insurance coverage for TMS for depression varies meaningfully by plan and prior-authorization criteria. We help you understand what your specific plan covers during your consultation and provide the documentation insurers typically require. Self-pay options are also available.

I take antidepressants — do I need to stop before EXOMIND?

Not necessarily. EXOMIND is cleared specifically for patients whose current antidepressant medication has not produced satisfactory improvement — many patients continue medication during treatment under physician supervision. Safety has not been established in patients who are unable to discontinue concurrent antidepressant medication; we work through this carefully in consultation.

What about anxiety, OCD, PTSD, or other conditions?

EXOMIND's FDA clearance is specifically for Major Depressive Disorder. Safety and effectiveness for OCD, PTSD, substance abuse history, psychotic disorders, and other conditions have not been established. Dr. Libreros can discuss what evidence does and does not support for related conditions during your consultation.

Where is treatment delivered?

At Neuromag Institute, 4914 N. Armenia Ave, Tampa, FL 33603. We see patients from across the Tampa metro — Tampa, Clearwater, Palm Harbor, Lutz, and St. Petersburg.

Talk to Dr. Libreros about EXOMIND.

The first conversation is unhurried. We review your history, screen for contraindications, and answer every question before anything else. No pressure, no commitment.

Book a consultationCall (813) 876-7246

EXOMIND™ and BTL® are trademarks or registered trademarks of BTL Industries.

EXOMIND TMS for Depression · Tampa · Neuromag Institute